Yafei Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yafei Xie has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Jianguo Xu
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China
2 shared publications - Qingyong Zheng
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China
2 shared publications - Bowen Zhang
Wuwei People’s Hospital of Gansu Province, Wuwei, Gansu, China
1 shared publication - Fang Li
Hunan University of Medicine, Huaihua, China
1 shared publication - Jiaxuan Sun
Department of Cardiovascular Surgery, Shaanxi Provincial People’s Hospital, Xi’an, China
1 shared publication - Jinhui Tian
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China
1 shared publication
Latest Publications
- Open Access
- 12 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (24) , e49199
Transforming healthcare: A bibliometric review of global blockchain integration and future trends
Background: The integration of blockchain technology in healthcare has garnered significant global interest, showing promising potential for revolutionizing this vital sector. This study presents a comprehensive analysis of blockchain-related publications in healthcare, aiming to offer an in-depth understanding of the field and forecast emerging trends. Material and methods: We employed the Web of Science Core Collection as our primary database for sourcing relevant literature. The data was meticulously analyzed using advanced tools such as VOSviewer 1.6.9, Bibliometrix 3.1.4, and CiteSpace 5.7.R2. Results: Our bibliometric analysis identified 218 scholarly articles on blockchain in healthcare since its first emergence in 2016. The research involved 683 institutions across 55 countries, with China and the United States leading in research output (> 90 publications each). The University of California, San Diego demonstrated the highest institutional productivity (n = 13). While the Journal of Medical Internet Research led in publication volume (39), Institute of Electrical and Electronics Engineers Access emerged as the most co-cited journal (654 citations). Thematic analysis revealed 6 major research clusters: personal health record systems, coranavirus disease 2019 response applications, remote healthcare services, security and privacy frameworks, implementation schemes and models, and smart contract development. Conclusions: The research landscape of blockchain in healthcare demonstrates rapid growth and increasing international collaboration. Current research frontiers focus on developing secure and privacy-preserving frameworks, particularly in health data management and pandemic response solutions, indicating promising directions for future healthcare transformation.
- 12 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (24) , e49199
Open AccessTransforming healthcare: A bibliometric review of global blockchain integration and future trends
Background: The integration of blockchain technology in healthcare has garnered significant global interest, showing promising potential for revolutionizing this vital sector. This study presents a comprehensive analysis of blockchain-related publications in healthcare, aiming to offer an in-depth understanding of the field and forecast emerging trends. Material and methods: We employed the Web of Science Core Collection as our primary database for sourcing relevant literature. The data was meticulously analyzed using advanced tools such as VOSviewer 1.6.9, Bibliometrix 3.1.4, and CiteSpace 5.7.R2. Results: Our bibliometric analysis identified 218 scholarly articles on blockchain in healthcare since its first emergence in 2016. The research involved 683 institutions across 55 countries, with China and the United States leading in research output (> 90 publications each). The University of California, San Diego demonstrated the highest institutional productivity (n = 13). While the Journal of Medical Internet Research led in publication volume (39), Institute of Electrical and Electronics Engineers Access emerged as the most co-cited journal (654 citations). Thematic analysis revealed 6 major research clusters: personal health record systems, coranavirus disease 2019 response applications, remote healthcare services, security and privacy frameworks, implementation schemes and models, and smart contract development. Conclusions: The research landscape of blockchain in healthcare demonstrates rapid growth and increasing international collaboration. Current research frontiers focus on developing secure and privacy-preserving frameworks, particularly in health data management and pandemic response solutions, indicating promising directions for future healthcare transformation.
- 18 February 2025
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 40 (1) , 303-315
Evaluating the Methodological Rigor and Recommendation Excellence of TAVR Guidelines: Insights from AGREE II and AGREE-REX Instruments
Purpose Transcatheter aortic valve replacement (TAVR) has emerged as a critical innovation for managing severe aortic stenosis, prompting the development of numerous clinical practice guidelines worldwide. This study systematically evaluates the guideline development methodologies of major international TAVR guidelines using the AGREE II and AGREE-REX instruments, aiming to enhance understanding of current development processes. Methods A comprehensive search was conducted in PubMed, Embase, Web of Science, and specialized guideline repositories. Twenty-four TAVR-specific guidelines were independently evaluated by four reviewers using the AGREE II and AGREE-REX instruments. The guidelines were categorized as evidence- or consensus-based, and statistical analysis was performed using SPSS to standardize scores and assess inter-rater reliability. Results Systematic assessment revealed significant methodological variations across guidelines. The AGREE II evaluation showed the highest performance in scope and purpose (83.9 ± 10.0%) but lower scores in rigor of development (43.5 ± 29.0%) and applicability (42.4 ± 26.8%). The AGREE-REX analysis demonstrated stronger performance in implementability (78.6 ± 14.5%) while identifying gaps in the integration of values and preferences (35.7 ± 17.2%). Evidence-based guidelines consistently outperformed consensus-based ones across multiple domains, particularly in terms of methodological rigor and implementation planning. Discussion This evaluation highlights key areas for improving guideline development methodology, including standardized evidence evaluation processes, systematic stakeholder engagement, and structured implementation planning. The considerable variability in methodological quality underscores the need for more standardized approaches. Conclusion Current TAVR guidelines exhibit significant heterogeneity in methodological quality, with evidence-based guidelines demonstrating superior performance in development rigor and implementation planning. Systematic approaches to evidence synthesis and stakeholder engagement are crucial for high-quality guideline development.
- 18 February 2025
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 40 (1) , 303-315
Evaluating the Methodological Rigor and Recommendation Excellence of TAVR Guidelines: Insights from AGREE II and AGREE-REX Instruments
Purpose Transcatheter aortic valve replacement (TAVR) has emerged as a critical innovation for managing severe aortic stenosis, prompting the development of numerous clinical practice guidelines worldwide. This study systematically evaluates the guideline development methodologies of major international TAVR guidelines using the AGREE II and AGREE-REX instruments, aiming to enhance understanding of current development processes. Methods A comprehensive search was conducted in PubMed, Embase, Web of Science, and specialized guideline repositories. Twenty-four TAVR-specific guidelines were independently evaluated by four reviewers using the AGREE II and AGREE-REX instruments. The guidelines were categorized as evidence- or consensus-based, and statistical analysis was performed using SPSS to standardize scores and assess inter-rater reliability. Results Systematic assessment revealed significant methodological variations across guidelines. The AGREE II evaluation showed the highest performance in scope and purpose (83.9 ± 10.0%) but lower scores in rigor of development (43.5 ± 29.0%) and applicability (42.4 ± 26.8%). The AGREE-REX analysis demonstrated stronger performance in implementability (78.6 ± 14.5%) while identifying gaps in the integration of values and preferences (35.7 ± 17.2%). Evidence-based guidelines consistently outperformed consensus-based ones across multiple domains, particularly in terms of methodological rigor and implementation planning. Discussion This evaluation highlights key areas for improving guideline development methodology, including standardized evidence evaluation processes, systematic stakeholder engagement, and structured implementation planning. The considerable variability in methodological quality underscores the need for more standardized approaches. Conclusion Current TAVR guidelines exhibit significant heterogeneity in methodological quality, with evidence-based guidelines demonstrating superior performance in development rigor and implementation planning. Systematic approaches to evidence synthesis and stakeholder engagement are crucial for high-quality guideline development.
- Open Access
- 29 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (48) , e40729
A comprehensive review of biomarker research in diabetic nephropathy from a global bibliometric and visualization perspective
Background: Diabetic nephropathy (DN) is a common complication of diabetes, which is prone to develop into end-stage renal disease, and early diagnosis and treatment is the key to effective management of DN. Biomarkers have important clinical significance in the diagnosis and treatment of DN and have attracted extensive attention from researchers in recent years. The aim of this study was to visualize the field of biomarker research in DN through bibliometric analysis, to summarize the current status and predict future trends of this field, with a view to providing valuable insights for scholars and policy makers. Methods: Literature search and data collection from Web of Science Core Collection. Calculations and visualizations were performed using Microsoft Excel, VOSviewer, Bibliometrix R-package, and CiteSpace. Results: We identified 1274 publications about biomarker research in DN from 1995 to November 01, 2023, with a steady increase in annual publications. China, Steno Diabetes Center in Denmark, and Frontiers in Endocrinology were the most productive country, institution, and journal, respectively; Mischak, Harald was both the most productive and highly cited author, and Kidney International was the most cited journal. The high frequency keywords were “albuminuria,” “chronic kidney disease” and “expression.” In addition, “macrophage,” “fibrosis” and “omics” are potentially promising topics. Conclusion: Our study comprehensively and visually summarized the important findings of global biomarker research in DN and revealed the structure, hotspots, and evolutionary trends in this field. It would inspire subsequent studies from a macroscopic perspective and provide a basis for rational allocation of resources and identification of collaborations among researchers.
- 29 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (48) , e40729
Open AccessA comprehensive review of biomarker research in diabetic nephropathy from a global bibliometric and visualization perspective
Background: Diabetic nephropathy (DN) is a common complication of diabetes, which is prone to develop into end-stage renal disease, and early diagnosis and treatment is the key to effective management of DN. Biomarkers have important clinical significance in the diagnosis and treatment of DN and have attracted extensive attention from researchers in recent years. The aim of this study was to visualize the field of biomarker research in DN through bibliometric analysis, to summarize the current status and predict future trends of this field, with a view to providing valuable insights for scholars and policy makers. Methods: Literature search and data collection from Web of Science Core Collection. Calculations and visualizations were performed using Microsoft Excel, VOSviewer, Bibliometrix R-package, and CiteSpace. Results: We identified 1274 publications about biomarker research in DN from 1995 to November 01, 2023, with a steady increase in annual publications. China, Steno Diabetes Center in Denmark, and Frontiers in Endocrinology were the most productive country, institution, and journal, respectively; Mischak, Harald was both the most productive and highly cited author, and Kidney International was the most cited journal. The high frequency keywords were “albuminuria,” “chronic kidney disease” and “expression.” In addition, “macrophage,” “fibrosis” and “omics” are potentially promising topics. Conclusion: Our study comprehensively and visually summarized the important findings of global biomarker research in DN and revealed the structure, hotspots, and evolutionary trends in this field. It would inspire subsequent studies from a macroscopic perspective and provide a basis for rational allocation of resources and identification of collaborations among researchers.